Company Filing History:
Years Active: 2014-2020
Title: Innovations of Steven J Blaisdell
Introduction
Steven J Blaisdell is an accomplished inventor based in Jackson, NJ (US). He has made significant contributions to the field of biotechnology, particularly in the production of pegylated interleukin-10 (IL-10). With a total of 4 patents to his name, Blaisdell's work has the potential to impact therapeutic applications significantly.
Latest Patents
Among his latest patents are methods for producing mono- and di-pegylated IL-10. These innovations provide essential techniques for enhancing the efficacy of IL-10 in various medical applications. The methods outlined in his patents are crucial for advancing research in immunotherapy and related fields.
Career Highlights
Blaisdell is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His role at Merck has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development projects.
Collaborations
Some of his notable coworkers include Collette Marie Cutler and Brittany C Paporello. Their collaborative efforts have further enriched the research environment at Merck, fostering innovation and creativity in their projects.
Conclusion
Steven J Blaisdell's contributions to biotechnology through his patents and work at Merck Sharp & Dohme Corp. highlight his role as a significant inventor in the field. His innovations in pegylated IL-10 production are paving the way for future advancements in therapeutic applications.